Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 4Completed 4Withdrawn 2Recruiting 2Not yet recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 34Pancreatic Neoplasms 14Neuroblastoma 13Neoplasm Metastasis 11Stomach Neoplasms 9Neoplasms 8Rectal Neoplasms 5Small Cell Lung Carcinoma 4Esophageal Squamous Cell Carcinoma 4Colonic Neoplasms 4Sarcoma, Ewing 3Rhabdomyosarcoma 3Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Wilms Tumor 2Sarcoma 2Recurrence 2Osteosarcoma 2Ganglioneuroblastoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Solid Tumors 1

Interventions

Gemcitabine 23Cisplatin 22durvalumab 13pembrolizumab 8Oxaliplatin 7Capecitabine 7Fluorouracil 6Leucovorin 5Bevacizumab 5lenvatinib 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4Nivolumab 3Liquid Biopsy 3Injections 3Folfox protocol 3zanidatamab 2trifluridine tipiracil drug combination 2tremelimumab 2tislelizumab 2ivosidenib 2futibatinib 2apatinib 2Trastuzumab 2Taxes 2Irinotecan 2Immune Checkpoint Inhibitors 2Drug Therapy 2Carboplatin 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Biliary Tract Neoplasms × Irinotecan × Clear all
NCT07265674 2026-05-14

Beacon-BTC

J-Pharma Co., Ltd.

Phase 3 Recruiting
480 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT06219941 2026-02-12

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

AstraZeneca

Phase 2 Recruiting
224 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡